ILTS TEE Simulation Session

To all providers involved in perioperative care of liver transplant patients:

Transesophageal echocardiography (TEE) is emerging as an important monitor for patients undergoing liver transplantation. We invite those who are interested in learning more about TEE and its utility in liver transplantation to attend this special workshop at ILTS 2018! The workshop will consist of an introduction to TEE and hands-on experience with TEE simulators.

Workshop Objectives:
• Demonstrate utility of intraoperative TEE for liver transplantation
• Acquire standard TEE views pertinent to liver transplantation
• Identify intraoperative TEE findings that are relevant to liver transplantation
• Utilize simulation to become familiar with TEE

This workshop will be offered at NO cost for those who sign-up in advance!

Location: Room 1.15

Timing: Session 1: 12:00 – 14:00
Session 2: 14:30 – 16:30

Registration: First come first served, please ensure your availability prior to registration

Post-Graduate Course: Changing scenarios in liver transplantation

Wednesday, May 23, 13:00 16:50  in Auditorium 2

Patrizia Burra, Padua, Italy
Josh Levitsky, United States
John Roberts, United States

13:00 – 13:15
Patrizia Burra, Padua, Italy

13:15 – 14:15
Session one: Non alcoholic steato-hepatitis

Critical variables in the evaluation of NASH end stage liver disease candidates
Luca Miele, Catholic University of the Sacred Heart Milano, Lazio, Italy

New therapeutic options for NASH and NAFLD to prevent end-stage liver disease
Franck Tacke, Germany

Is there a need to modify immunosuppression regimens in the management of recurrent and de novo NASH after liver transplantation?
Emmanuel Tsochatzis, United Kingdom

14:15 – 14:25

14:25 – 15:25
Session 2: Hepatitis B virus-related liver disease

Liver transplantation for acute HBV hepatitis: Déjà vu
Didier Samuel, Université Paris-Sud, Villejuif, France

HBsAg and anti-HCV positive donors: Should we push for increased use in deceased and living donor liver transplantation?
Paolo Grossi, University of Insubria, Varese, Italy

The role of HBIg in long-term prophylaxis of HBV recurrence
Krzysztof Zieniewicz, Warsaw, Poland

15:25 – 15:35

15:35 – 16:35
Session three: Hepatocellular carcinoma and Cholangiocarcinoma

Is it time for a new consensus on criteria for listing patients with HCC?
Pierre-Alan Clavien, Switzerland

mTORi as standard immunosuppression in patients transplanted for HCC. What do the data show?
Edward Geissler, Regensburg, Germany

Liver transplantation for cholangiocarcinoma: selection, pre-transplant treatment, outcome
Julie Heimbach, Mayo Clinc, Rochester, United States

16:35 – 16:45

16:45 – 16:50
Closing remarks
Patrizia Burra, Padua, Italy